PharmaTwist Bioscience Expects Triple-Digit AI Drug Discovery Growth Through FY27
Minimum triple-digit growth sets the company’s AI orders to surge from ~$25M in FY25 to at least $100M by FY27.
Pharma · Company
Twist Bioscience Corporation
Covered since Most recent
Twist Bioscience Corporation anticipates significant growth in its AI drug discovery segment, projecting an increase in AI orders from approximately $25 million in FY25 to at least $100 million by FY27.
0Stories
+0 in the last 30 days
0Deployments tracked
1 live
100MAI orders by FY27
Latest tracker entry
Deployments
In the tracker →- AI-enabled drug discovery
live100M drug discovery
Stories
1 storyPharma
